Literature DB >> 10755734

Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity.

C A Stewart1, I C Reid.   

Abstract

RATIONALE: Recent studies have implicated intracellular transduction pathways and neurotrophic factors in the action of antidepressants. Adaptation in these pathways may ultimately affect electrophysiological and morphological properties of neurones. We have previously shown that repeated electroconvulsive stimulation, a safe and effective antidepressant treatment, has profound effects on hippocampal synaptic connectivity and plasticity in the rat. Here, we investigated whether these electrophysiological properties were shared by the chemical antidepressant, fluoxetine.
OBJECTIVES: To compare the electrophysiological and cognitive effects of two very different antidepressant treatments: repeated electroconvulsive stimulation (rECS); and chronic administration of the serotonin specific re-uptake inhibitor (SSRI), fluoxetine.
METHODS: Rats were exposed to either rECS or daily fluoxetine administration for 15 days. The animals were then anaesthetised and dentate field excitatory post-synaptic potential (fEPSP) characteristics were measured before and after the induction of long-term potentiation (LTP) by high frequency perforant path stimulation. In a separate experiment, the effects of rECS and chronic fluoxetine administration on acquisition and retention of a spatial learning task in the Morris watermaze were determined.
RESULTS: Chronic fluoxetine administration and rECS produced equivalent increases in dentate fEPSP compared to respective control groups. LTP induction was attenuated in both groups. Spatial learning was, in contrast, unaffected by fluoxetine treatment but significantly impaired following rECS.
CONCLUSIONS: Given that fluoxetine and rECS share antidepressant properties, but differ in their effects on learning and memory, we propose that the common effects on dentate connectivity and synaptic plasticity described here are more likely to relate to affective rather than cognitive function. This result is consistent with other experiments showing that a reduction in dentate connectivity correlates with stress susceptibility in animals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10755734     DOI: 10.1007/s002130050045

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

Review 1.  Brain plasticity and antidepressant treatments: new cells, new connections.

Authors:  Ian C Reid; Caroline A Stewart
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 2.  Targeting the hippocampal mossy fiber synapse for the treatment of psychiatric disorders.

Authors:  Katsunori Kobayashi
Journal:  Mol Neurobiol       Date:  2009-01-08       Impact factor: 5.590

Review 3.  Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.

Authors:  Gerard Sanacora; Giulia Treccani; Maurizio Popoli
Journal:  Neuropharmacology       Date:  2011-08-03       Impact factor: 5.250

4.  Fluoxetine and the dentate gyrus: memory, recovery of function, and electrophysiology.

Authors:  Julian R Keith; Ying Wu; Jonathon R Epp; Robert J Sutherland
Journal:  Behav Pharmacol       Date:  2007-09       Impact factor: 2.293

5.  Neuronal plasticity and antidepressant actions.

Authors:  Eero Castrén; René Hen
Journal:  Trends Neurosci       Date:  2013-02-01       Impact factor: 13.837

6.  Fluoxetine protects hippocampal plasticity during conditioned fear stress and prevents fear learning potentiation.

Authors:  Guillaume Spennato; Carine Zerbib; Cesare Mondadori; René Garcia
Journal:  Psychopharmacology (Berl)       Date:  2007-11-09       Impact factor: 4.530

Review 7.  Neuropeptides in depression: role of VGF.

Authors:  Smita Thakker-Varia; Janet Alder
Journal:  Behav Brain Res       Date:  2008-10-15       Impact factor: 3.332

8.  Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.

Authors:  Marwa Aboukhatwa; Laura Dosanjh; Yuan Luo
Journal:  Mol Neurodegener       Date:  2010-03-12       Impact factor: 14.195

9.  Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: the impact of medication.

Authors:  Jonathan Savitz; Allison C Nugent; Wendy Bogers; Alice Liu; Rebecca Sills; David A Luckenbaugh; Earle E Bain; Joseph L Price; Carlos Zarate; Husseini K Manji; Dara M Cannon; Sean Marrett; Dennis S Charney; Wayne C Drevets
Journal:  Neuroimage       Date:  2009-11-17       Impact factor: 6.556

Review 10.  Imaging phenotypes of major depressive disorder: genetic correlates.

Authors:  J B Savitz; W C Drevets
Journal:  Neuroscience       Date:  2009-04-07       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.